Inhibitors of cyclooxygenase-2 (COX-2) suppressed the proliferation and differentiation of human leukaemia cell lines

被引:62
|
作者
Nakanishi, Y [1 ]
Kamijo, R [1 ]
Takizawa, K [1 ]
Hatori, M [1 ]
Nagumo, M [1 ]
机构
[1] Showa Univ, Sch Dent, Dept Oral & Maxillofacial Surg 2, Ota Ku, Tokyo 1458515, Japan
关键词
U-937; ML-1; COX-2; inhibitor; NS-398; nabumetone; proliferation; differentiation; G0/G1; arrest;
D O I
10.1016/S0959-8049(01)00160-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Prostaglandins (PG) are known to play important roles in the proliferation and differentiation of leukaemia cells. The effect of the inhibitors of cyclooxygenase-2 (COX-2), a rate-limiting enzyme for the synthesis of PG, on the proliferation and differentiation of leukaemia cell lines was investigated. COX-2 inhibitors, NS-398 and nabumetone, suppressed the proliferation of U-937 and ML-1 cells by inducing a G0/G1 cell-cycle arrest. Cell-cycle arrest induced by these COX-2 inhibitors was not associated with an upregulation of the cyclin-dependent kinase inhibitors. COX-2 inhibitors also inhibited the differentiation of these cells induced by interferon-gamma (IFN-gamma), tumour necrosis factor-alpha (TNF-alpha) and retinoic acid (RA). Treatment with NS-398 did not suppress the levels of PGs produced by these cells. Although COX-2 antisense oligonucleotide showed a similar inhibitory effect on these cells, its inhibitory effect was smaller than that of NS-398, These results suggest that COX-2 inhibitors may suppress the proliferation and differentiation of leukaemia cells both via COX-2-dependent and -independent pathways. (C) 2001 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:1570 / 1578
页数:9
相关论文
共 50 条
  • [21] Expression of cyclooxygenase-2 (COX-2) in pituitary tumours
    Sokolowski, Grzegorz
    Baldys-Waligorska, Agata
    Trofimiuk, Malgorzata
    Adamek, Dariusz
    Hubalewska-Dydejczyk, Alicja
    Golkowski, Filip
    MEDICAL SCIENCE MONITOR, 2012, 18 (04): : CR252 - CR259
  • [22] Cyclooxygenase-2 (COX-2) expression in human meningioma as a function of tumor grade
    Lin, CD
    Kenyon, L
    Hyslop, T
    Hammond, E
    Andrews, DW
    Curran, WJ
    Dicker, AP
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2003, 26 (04): : S98 - S102
  • [23] Synthesis and evaluation of fluorobenzoylated di- and tripeptides as inhibitors of cyclooxygenase-2 (COX-2)
    Sharma, Sai Kiran
    Al-Hourani, Baker Jawabrah
    Wuest, Melinda
    Mane, Jonathan Y.
    Tuszynski, Jack
    Baracos, Vickie
    Suresh, Mavanur
    Wuest, Frank
    BIOORGANIC & MEDICINAL CHEMISTRY, 2012, 20 (07) : 2221 - 2226
  • [24] Radiosensitization of human glioma cells by cyclooxygenase-2 (COX-2) inhibition: Independent on COX-2 expression and dependent on the COX-2 inhibitor and sequence of administration
    Kuipers, Gitta K.
    Slotman, Ben J.
    Wedekind, Laurine E.
    Stoter, T. Rianne
    Van Den Berg, Jaap
    Sminia, Peter
    Vincent, M.
    Lafleur, M.
    INTERNATIONAL JOURNAL OF RADIATION BIOLOGY, 2007, 83 (10) : 677 - 685
  • [25] Fibronectin stimulates human lung carcinoma cell growth by inducing cyclooxygenase-2 (cox-2) expression
    Han, SW
    Sidell, N
    Roser-Page, S
    Roman, J
    INTERNATIONAL JOURNAL OF CANCER, 2004, 111 (03) : 322 - 331
  • [26] Cyclooxygenase-2 (Cox-2) in injured human nerve and a rat model of nerve injury
    Durrenberger, PF
    Facer, P
    Gray, RA
    Chessell, IP
    Naylor, A
    Bountra, C
    Banati, RB
    Birch, R
    Anand, P
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2004, 9 (01) : 15 - 25
  • [27] Cyclooxygenase-2 (COX-2) in acute myocardial infarction: cellular expression and use of selective COX-2 inhibitor
    Saito, T
    Rodger, I
    Shennib, H
    Hu, F
    Tayara, L
    Giaid, A
    CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2003, 81 (02) : 114 - 119
  • [28] Novel 5-substituted 1H-tetrazoles as cyclooxygenase-2 (COX-2) inhibitors
    Al-Hourani, Baker Jawabrah
    Sharma, Sai Kiran
    Suresh, Mavanur
    Wuest, Frank
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (06) : 2235 - 2238
  • [29] Differential effects of selective COX-2 inhibitors on cell cycle regulation and proliferation of glioblastoma cell lines
    Kardosh, A
    Blumenthal, M
    Wang, WJ
    Chen, TC
    Schönthal, AH
    CANCER BIOLOGY & THERAPY, 2004, 3 (01) : 55 - 62
  • [30] Renal cyclooxygenase-2 (Cox-2) -: Physiological, pathophysiological, and clinical implications
    Krämer, BK
    Kammerl, MC
    Kömhoff, M
    KIDNEY & BLOOD PRESSURE RESEARCH, 2004, 27 (01) : 43 - 62